Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

Skip to main content

Table 3 Comparison of clinical and process characteristics for open and closed tibial fractures (n = 358)

From: Economics of open tibial fractures: the pivotal role of length-of-stay and infection

 

Patients

Open (n = 51)

Closed (n = 307)

p

Clinical characteristics

Gender

  

0.079

-Male

33 (64.7%)

158 (51.5%)

 

-Female

18 (35.3%)

149 (48.5%)

 

Age (years)

48 (29 – 60)

49 (37 – 63)

0.242

ASA score

  

0.298

-ASA 1

19 (37.3%)

139 (45.3%)

 

-ASA 2

23 (45.1%)

135 (44.0%)

 

-ASA 3

9 (17.6%)

33 (10.7%)

 

CVRF

26 (59.1%)

172 (58.9%)

0.981

AO/OTA bone segment

  

<0.001***

-41

6 (11.8%)

116 (37.8%)

 

-42

31 (60.8%)

109 (35.5%)

 

-43

14 (27.5%)

82 (26.7%)

 

AO/OTA fracture type

  

0.010**

-A

22 (43.1%)

97 (31.6%)

 

-B

10 (19.6%)

129 (42.0%)

 

-C

19 (37.3%)

81 (26.4%)

 

AO/OTA fracture group

  

0.190

-1

21 (41.2%)

141 (45.9%)

 

-2

12 (23.5%)

42 (13.7%)

 

-3

18 (35.3%)

124 (40.4%)

 

Antibiotic therapy

  

<0.001***

-prophylactic

27 (52.9%)

286 (93.2%)

 

-therapeutic

24 (47.1%)

21 (6.8%)

 

Delayed-staged surgery

17 (33.3%)

27 (8.8%)

<0.001***

Type of definite surgery

  

<0.001***

-intramedullary nail

35 (68.6%)

105 (34.2%)

 

-plate osteosynthesis

14 (27.5%)

130 (42.3%)

 

-screw osteosynthesis

0

66 (21.5%)

 

-external fixator

2 (3.9%)

5 (1.6%)

 

-arthrodesis

0

7 (2.3%)

 

Superficial infection

0

0 (3.9%)

0.276

Deep infection

7 (13.7%)

5 (1.6%)

<0.001***

Nonunion

10 (19.6%)

8 (2.6%)

<0.001***

Other complications

2 (3.9%)

6 (2.0%)

0.379

Debridement

10 (19.6%)

9 (2.9%)

<0.001***

Hardware removal

25 (49.0%)

96 (31.3%)

0.013*

Re-osteosynthesis

8 (15.7%)

6 (2.0%)

<0.001***

Other operations

10 (19.6%)

12 (3.9%)

<0.001***

Mortality

1 (2.0%)

10 (3.3%)

0.619

Process characteristics

LOS to definite surgery (days)

0 (0 – 5)

1 (0 – 3)

0.950

Total length of antibiotic therapy (days)

6 (4 – 11)

1 (1 – 2)

<0.001***

Total LOS (days)

11 (7 – 25)

6 (4 – 13)

<0.001***

Number of operations

2 (1 – 3)

1 (1 – 2)

<0.001***

Number of hospital admissions

1 (1 – 2)

1 (1 – 2)

<0.015*

Number of surgical day care admissions

0

0

0.883

Number of ambulatory consults

7 (5 – 10)

5 (3 – 7)

<0.001***

Healthcare costs

Honoraria

€2,609 (1,484 – 4,013)

€1,494 (1,135 – 2,281)

<0.001***

Materials (implants & screws)

€1,617 (1,070 – 2,501)

€1,002 (467 – 1,397)

<0.001***

Hospitalization

€4,519 (2,876 – 10,271)

€2,465 (1,643 –5,341)

<0.001***

Day care stay

€0 (0 – 177)

€0 (0 – 86)

0.588

Pharmaceuticals

€1,448 (981 – 3294)

€978 (862 – 1,724)

<0.001***

Total healthcare costs

€11,061 (7,135 – 19,883)

€6,632 (4,714 – 10,095)

<0.001***

  1. Categorical variables are presented as numbers and percentages, continuous variables as median with interquartile distributions
  2. *p < 0.05, **p ≤ 0.01, ***p < 0.001 (p < 0.05 is considered to be significant)
  3. Abbreviations: CVRF cardiovascular risk factors, LOS length of stay